Insider Profile
Page, Jonathan
1
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Dec 01, 2020
Most Recent Trade
31
Credibility
Score
83%
Hit Rate
+9.0%
Avg 90d Return
+20.1%
Median 90d Return
6
Evaluated Trades
+29.6%
Best Trade
-56.2%
Worst Trade
Hit rate and returns are based on 6 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
Hit Rate · 90d
-18.6%
Median Alpha · 90d
2
Closed Buys Evaluated
0%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
cluster buyer size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 2 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Dec 01, 2020 $ACB
Aurora Cannabis
Open Market Buy 233,908 10
Dec 01, 2020 $ACB
Aurora Cannabis
Open Market Buy 467,817 $10.10 $4.7M 10
Sep 10, 2020 $ACB
Aurora Cannabis
Comp. Grant Buy 18,933 10
Sep 10, 2020 $ACB
Aurora Cannabis
Comp. Grant Buy 18,933 10
Sep 10, 2020 $ACB
Aurora Cannabis
Comp. Grant Buy 3,780 10
Feb 10, 2020 $ACB
Aurora Cannabis
Comp. Grant Buy 150,000 10
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.